Mason Carrico

Stock Analyst at Stephens & Co.

(1.73)
# 3,133
Out of 4,856 analysts
81
Total ratings
29.41%
Success rate
-9.91%
Average return

Stocks Rated by Mason Carrico

Vericel
May 22, 2025
Reiterates: Overweight
Price Target: $67
Current: $43.30
Upside: +54.73%
Illumina
May 20, 2025
Reiterates: Overweight
Price Target: $105
Current: $82.66
Upside: +27.03%
Pacific Biosciences of California
May 15, 2025
Reiterates: Overweight
Price Target: $1.8
Current: $1.14
Upside: +57.89%
10x Genomics
May 15, 2025
Reiterates: Overweight
Price Target: $14
Current: $9.42
Upside: +48.62%
Hologic
May 13, 2025
Maintains: Overweight
Price Target: $77$70
Current: $64.33
Upside: +8.81%
CareDx
May 5, 2025
Reiterates: Overweight
Price Target: $40
Current: $19.49
Upside: +105.23%
Glaukos
May 2, 2025
Maintains: Overweight
Price Target: $140$115
Current: $92.99
Upside: +23.67%
Veracyte
Mar 26, 2025
Reiterates: Overweight
Price Target: $45
Current: $27.46
Upside: +63.87%
OncoCyte
Mar 26, 2025
Reiterates: Equal-Weight
Price Target: $4
Current: $2.97
Upside: +34.68%
Guardant Health
Mar 26, 2025
Reiterates: Overweight
Price Target: $55
Current: $48.06
Upside: +14.44%
Downgrades: Equal-Weight
Price Target: $3.5$1.8
Current: $1.16
Upside: +55.17%
Reiterates: Overweight
Price Target: $6
Current: $3.44
Upside: +74.42%
Reiterates: Equal-Weight
Price Target: $17
Current: $17.89
Upside: -4.95%
Reiterates: Overweight
Price Target: $52
Current: $38.11
Upside: +36.45%
Reiterates: Equal-Weight
Price Target: $20
Current: $5.09
Upside: +292.93%
Reiterates: Overweight
Price Target: $41
Current: $17.60
Upside: +132.95%
Reiterates: Overweight
Price Target: $125
Current: $163.76
Upside: -23.67%
Reiterates: Overweight
Price Target: $19
Current: $7.42
Upside: +156.06%